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The antimicrobial activity of essential oils (EOs) and their constituents has led to 
increasing interest in using them as natural preservative agents. However, their high 
sensitivity to light and oxygen, their volatility, and their low aqueous solubility are all 
obstacles to their application in the food, cosmetic, or pharmaceutical industries. 
Encapsulation in cyclodextrins (CDs) is a solution for the application of EOs. 
 
RESULTS 
The complexation of carvacrol and thymol with hydroxypropyl (HP)-α-, HP-β-, and HP-
γ-CDs, the behavior of the solid complexes prepared by freeze-drying and spray-drying 
methods, and the antibacterial activity of solid complexes was studied. Kc values of HP-
α- and HP-γ-CD complexes with carvacrol (118.4 and 365.7 M-1) and thymol (112.5 and 
239.7 M-1) were far lower than those observed for HP-β-CD complexes with carvacrol 
(2268.2 M-1) and thymol (881.6 M-1). The lower stability of HP-α- and HP-γ-CD 
complexes increased the release of compounds, thereby affecting the antimicrobial 
activity of carvacrol and thymol to a lesser extent than complexation with HP-β-CD, 
normally used in the encapsulation of carvacrol and thymol. HP-β-CD encapsulation of 
carvacrol and thymol drastically reduced their antimicrobial activity. The freeze-drying 
method barely affected the antimicrobial activity of carvacrol and thymol after 
encapsulation, while spray-drying could be considered for the production of solid 







It was thus demonstrated that HP-α- and HP-γ-CD are a very suitable alternative for the 
encapsulation of carvacrol and thymol with the purpose of preserving their bacteriostatic 
and bactericidal activities. 
 
INTRODUCTION 
In recent years, the food industry has profoundly innovated in terms of food 
preservation processes and food safety. Essential oils (EOs), as well as their constituents, 
have been shown to be a powerful and natural antimicrobial agent against a large number 
of pathogens. 1 These antibacterial agents are extracted from natural sources, and are 
generally regarded as healthy, environmentally friendly, and safe,2 which makes them 
attractive to consumers.3 However, food industrial application of these compounds faces 
challenges that need to be solved, such as their limited aqueous solubility as well as their 
high volatility and instability against external agents such as light and oxygen, all of 
which render difficult a controlled release of the compounds and reduce their 
antimicrobial efficacy.4 
  One of the techniques most widely used to address these limitations has been 
encapsulation, comprising a wide and varied range of procedures such as freeze-drying, 
spray-drying, coacervation, gelation, precipitation, and nanoemulsion,4,5 as well as a wide 
range of encapsulating agents such as maltodextrins, gums, starch, chitosan, protein and 
zeins.4,5,6,7 
Among all the encapsulation alternatives for EOs and their components, the use 
of molecular encapsulation in cyclodextrins (CDs) stands out. CDs are cyclic oligomers 
that are widely used and recommended for industrial use as protectors for light-sensitive, 
oxygen-sensitive and heat-sensitive compounds, solubilizers of dyes and vitamins, flavor 
 
 
stabilizers, suppressants of flavors and unpleasant flavors, and regulators of controlled 
release of food additives and drugs.8  
Several authors have previously studied the effect of encapsulation in CDs on the 
solubility, stability, controlled release and bioactive properties, particularly the 
antimicrobial activity, of different EOs such as clove and oregano, 9 coriander, 10 thyme, 
11 cinnamon,3 basil and tarragon,12 Mentha x villosa Hudson,13 guava leaf,14 and pepper,15  
as well as some of their main components with high antimicrobial potential such as 
carvacrol and thymol.16,17,18,19,20 However, despite a wide range of existing literature, 
there is no consensus whether the encapsulation of these compounds in CDs positively or 
negatively affects their biological properties, especially their antimicrobial activity.21 
Although encapsulation in CDs increases the aqueous solubility of EOs and terpenes, the 
stability of the complex can affect the degree of release of the active compounds as well 
as their biological activity. 
In addition, the majority of previous studies almost exclusively focused on the use 
of β- and hydroxypropyl (HP)-β-CD, with almost no references to the encapsulation of 
EOs or their components with modified HP-α- or HP-γ-CDs. In a recent review of the 
characterization of volatile compounds encapsulated in CDs, Kfoury et al.22 provided 
more than 300 values of complexation constants with a series of CDs, but not with HP-
α- and HP-γ-CD. Rakmai et al.23 report 26 technological applications of complexed EOs 
in CDs, whereby 25 of them are focused on encapsulation with β- or HP-β-CD. On the 
other hand, Lima et al.24 published almost 150 references, of which only two consider the 
complexation of terpenes in HP-γ-CD and none in HP-α-CD. This preference for β- and 
HP-β-CDs is due to the greater compatibility of their hydrophobic cavity with most 
terpenes and oils with a reduced molecular weight (200-800 g/mol),25 which provides 
complexes with high stability. However, complexes with high stability can reduce 
 
 
compound release from CDs and limit their functional properties. It is therefore of great 
interest to study the ability to modulate the biological activity of antimicrobial compounds 
by complexing with other CDs, especially with modified ones such us HP-α- and HP-γ-
CDs, in order to obtain complexes with lower stability constants than those provided by 
the most widely used β- and HP-β-CDs. 
On the other hand, solid state CD complexes are another key aspect for food 
application, because solid state improves handling, stability, allows for standardized 
dosage of active compounds. The most frequently used methods for obtaining solid 
complexes of EOs are those that do not require high temperatures, such as freeze-drying, 
kneading, and precipitation.13,15,16,17,25 However, the use of the spray-drying method, 
despite being an easy system to perform on an industrial scale,5 is less widespread in the 
dehydration of EO complexes with CDs due to its high process temperature. Therefore, 
it is key to advance in the study of interactions between CD type and solid complex 
dehydration methods in order to modulate the biological activity of the encapsulated 
compounds for industrial applications. 
The aims of this study are, on the one hand, to study the effect that the stability of 
CD complexes has on the antimicrobial activity of carvacrol and thymol, introducing, in 
addition to the well-known HP-β-CDs, the modified HP-α-CD and HP-γ-CD, the 
behavior of which has not been previously described in the literature. On the other hand, 
the effect of the method of preparing solid complexes, via spray-drying as well as via 







MATERIAL AND METHODS 
Reagents and standards 
 Carvacrol (98 % purity) and thymol (99 % purity) were purchased from TCI 
Europe N.V. (Zwijndrecht, Belgium). The HP-α-, HP-β- and HP-γ-CDs were purchased 
from Winplus International Limited (Ningbo, China). HPLC reagents acetonitrile and 
water were purchased from JT Baker (Deventer, The Netherlands). Other chemical 
reagents used were of analytical grade. 
 
Complexation and phase solubility diagrams 
The complexation of carvacrol and thymol in CDs was carried out by phase 
solubility diagrams according to the method described by Higuchi and Connors with some 
modifications.26 Excess amounts of carvacrol and thymol were added to 50 mL of 
aqueous solutions in concentrations increasing from 0 to 50 mmol L-1 for HP-α-, HP-β- 
and HP-γ-CDs, and were continuously stirred during 24 h at 20 ºC in the dark. After 24 
h, solutions were filtered using 0.45 µm cellulose acetate membrane filters (Chromafil 
Macherey-Nagel, Düren, Germany) for HPLC assays. Phase solubility diagrams were 
made in triplicate. 
The complexation constant Kc between carvacrol and thymol and each type of CD 
was calculated from the slope of the phase solubility diagram and the solubility of the 




   (1) 
Complexation efficiency (CE) is the ratio between the dissolved complex and the 
concentration of free CDs. It is independent of S0, and was calculated from the slope of 
the phase solubility profiles by using the equation (2): 
 
 
𝐶𝐶𝐶𝐶 (%) = 𝑆𝑆𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
(1−𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠)
𝑥𝑥100  (2) 
 The molar ratio drug:cyclodextrin (D:C) was calculated using the CE value with 
the equation (3): 
𝐷𝐷:𝐶𝐶 = 1: �1 + 1
𝐶𝐶𝐶𝐶
�  (3) 
The solubilization potential (St/S0) was calculated as the relation between 
compound solubility at 50 mM CD concentration (St) and compound aqueous solubility 
(S0).  
 
Solid complexes by freeze-drying and spray-drying 
Solid complexes were obtained by dehydrating 100 mL volume with a molar 
proportion of 50:25 (CD:Compound) for HP-α-CD and HP-γ-CD, and 50:40 
(CD:Compound) for HP-β-CD. These molar proportions were selected according to the 
solubilization potential of the different CDs in order to ensure that all of the active 
compound was complexed. Solutions were continuously stirred during 24 h at 20 ºC in 
the dark. After 24 h, the solutions containing the complexes were either freeze- or spray-
dried.  
Solutions of carvacrol and thymol complexes were freeze-dried in a Christ Alpha 
1-2 LD Plus (Martin Christ, Osterode am Harz, Germany) freeze dryer at -48 ºC during 
three days. Solutions of carvacrol and thymol complexes were spray-dried in a Buchi B-
290 device (Flawil, Switzerland). The spray drier configuration was: inlet air temperature 
170 ºC, outlet air temperature 68 ºC, inlet air flow 35 m3 h-1, pump flow 5 mL min-1, and 
compressed air caudal 360 L h-1. The recovered freeze- and spray-dried solid complexes 
were stored in an airtight glass container for posterior analysis and characterization. For 
carvacrol and thymol HPLC quantification, solid complexes were dissolved in distilled 
 
 
water and filtered using 0.45 µm cellulose acetate membrane filters (Chromafil 
Macherey-Nagel, Düren, Germany).  
The dehydration yield (DY) was calculated using the equation: 
DY (%) = solid complexes obtained (g)
total solids in solution (g)
· 100  (4) 
 The encapsulation efficiency (EE) was calculated using the equation: 
EE (%) = total compound encapsulated in solid complex (mg)
initial total compound in solution (mg)
· 100   (5) 
 The drug load (DL) was calculated using the equation: 
DL (mg 𝑔𝑔−1) = total compound encapsulated in solid complex (mg)
total solid complexes (g)
   (6) 
Wettability is defined as the time taken by a solid to completely submerge in a 
humid medium. The analysis was carried out by gently dropping 500 mg of powder on 
the surface of 100 mL of distilled water at 20 ºC.  
Encapsulation efficiency, drug load, and wettability were measured in triplicate 
for each sample for purposes of statistical analysis. 
 
Carvacrol and thymol determination by HPLC  
Carvacrol and thymol were quantified by HPLC analysis using an HPLC Agilent 
Technologies Model 1200 (Agilent, Santa Clara, California, USA) equipped with a diode 
array detector set at 280 nm, injecting 20 µL of filtered complexes. Separations were 
carried out on an endcapped (5 µm) HPLC Cartridge 250-4 LiChospher 100 RP-18. The 
column temperature was set to 30 ºC, and the flow rate was 0.7 mL min-1. The mobile 
phase was water with 0.5 % of acetic acid (A) versus acetonitrile (B), for a total running 
time of 7 min and a constant proportion of 20 % (A) 80 % (B). Time retentions were 4.3 
min for carvacrol and 4.1 min for thymol. The data were processed by Agilent 




Particle size and shape 
 Shape and structural characteristics of the solid complexes were studied by Field 
Emission Scanning Electron Microscope (FESEM) images. Uncoated samples were 
examined using a MERLIN™ VP COMPACT SEM microscope (Carl Zeiss Microscopy, 
Oberkochen, Germany). Images detailing morphology were taken using an SE2 detector 
under an accelerating voltage of 1 kV.  
 
Antibacterial activity 
Bacteria and growth conditions  
Escherichia coli O157:H7 Sakai/stx1A/stx2A was kindly provided by Kyu-Tae 
Chang.27 FPR3757 strain of methicillin-resistant Staphylococcus aureus USA300 was 
provided by Prof. Kolter (Harvard Medical School, Boston, MA, USA). This strain was 
isolated from an outbreak in the United States.28  
Throughout this investigation, both strains were kept at -80 °C in cryovials with 
glycerol. To prepare the broth subcultures, one single colony from a tryptone soya agar 
plate supplemented with 0.6 % yeast extract (Oxoid, Basingstoke, Hampshire, England; 
TSAYE) was inoculated in a test tube with 5 mL of sterile tryptone soya broth with 0.6 
% yeast extract added (Oxoid; TSBYE). The inoculated tubes were incubated overnight 
in aerobic conditions at 37 °C (Selecta Incudigit, Barcelona, Spain) to obtain bacterial 
subcultures. 250 mL Erlenmeyer flasks containing 50 mL of TSBYE were inoculated 
with those subcultures to a final concentration of 105 colony forming units (CFU) mL-1. 
To reach the stationary growth phase (2 x 109 CFU mL-1 approximately), bacterial 




Disk diffusion test 
A modified disk diffusion test was applied in order to screen the antimicrobial 
activity of carvacrol and thymol encapsulated in HP-α-, HP-β- and HP-γ-CDs against E. 
coli O157:H7 Sakai and S. aureus USA300.29 Filter paper disks (Whatman No. 1; 
diameter: 6 mm) containing 600 µg of encapsulated active compound were applied on 
TSAYE plates that had been previously inoculated with a diluted culture (0.5 McFarland) 
and spread on the surface. For a period of 24 h, the plates were incubated at the 
appropriate temperature (37 ºC), and the resulting zone of partial inhibition was observed.  
 
Minimum inhibitory and bactericidal concentration (MIC and MBC) 
The MIC and MBC of carvacrol and thymol, free and encapsulated in HP-α, HP-
β and HP-γ-CD, were evaluated against E. coli O157:H7 Sakai and S. aureus USA300 
with the purpose of studying the encapsulation effect on the antimicrobial properties of 
those two compounds following a protocol adapted from CLSI (2015). Test tubes 
containing 5 mL of Mueller Hinton broth (Oxoid; MHB) with a diluted (105 CFU mL-1) 
stationary phase culture were inoculated with CD-encapsulated thymol and carvacrol at 
different concentrations (from 150 to 1,000 mg L-1 at intervals of 50 mg L-1). 
Subsequently, test tubes were incubated at 37 ºC for 24 h in a shaking thermostatic 
incubator (Bunsen, mod. BTG, Madrid, Spain) at 130 rpm. Positive controls containing 
MHB with microbial cultures at 105 CFU mL-1 without carvacrol and thymol, as well as 
negative controls containing MHB with encapsulated carvacrol and thymol without 
bacteria were also prepared. MIC was determined as the lowest concentration of carvacrol 
or thymol in the presence of which bacteria showed no visible growth. Additionally, test 
tubes were aliquoted and spread onto Mueller Hinton agar plates (Oxoid, MHA), and, 
after incubation (37 ºC / 24 h), survivors were counted with an improved image analyzer 
 
 
automatic counter (Protos; Analytical Measuring Systems, Cambridge, United Kingdom). 
The MBC was set as the minimum concentration of the compound that inactivated more 
than 3 log10 cycles (< 102 UFC mL-1).  
 
RESULTS AND DISCUSSION 
Complexation of carvacrol and thymol in HP-α-, HP-β- and HP-γ-CD 
The phase diagrams of carvacrol and thymol encapsulated in HP-α-, HP-β- and 
HP-γ-CD are shown in Figure 1. The phase solubility diagrams showed an AL type profile, 
for both compounds and for all CDs, indicating that water-soluble complexes had been 
formed. In all cases studied, the slope of the solubility diagrams was lower than 1, 
indicating that the stoichiometry of the complexes was 1:1, whereby each molecule of 
carvacrol or thymol enters into one molecule of CD.26 The same AL diagram was 
previously observed for carvacrol and thymol encapsulated in HP-β-CDs by Kamimura 
et al. and Kfoury et al.,16,18 thereby suggesting that this 1:1 stoichiometry is common for 
these compounds.30 To the best of our knowledge, these are the first published results on 
the subject of carvacrol and thymol encapsulation with HP-α- and HP-γ-CDs.  
From the information plotted in phase diagrams, different parameters that 
characterize the complexation of these compounds in CDs were calculated. Table 1 shows 
complexation constant (Kc), complexation efficiency (CE), molar ratio (D:C), and 
solubilization potential (St/S0) of HP-α-, HP-β-, and HP-γ-CD complexes.  
 The complexation constant (Kc) was calculated by using linear regression analysis 
from the phase solubility diagrams according to equation (1). One can observe that the 
highest values of Kc were obtained for HP-β-CD. The Kc values for carvacrol and thymol 
encapsulated in HP-β-CD were 2268.2 L mol-1 and 881.6 L mol-1 respectively. These 
values are similar to those obtained by Kfoury et al.18 Kc values of carvacrol and thymol 
 
 
complexes with HP-α- and HP-γ-CD were significantly lower (p < 0.05) than those 
obtained for HP-β-CD. Kc values for HP-α-CD were 118.5 and 112.5 L mol-1, and for 
HP-γ-CD they were 365.7 and 237.7 L mol-1 for carvacrol and thymol, respectively. Kc 
values lay, in general, within the range of 200 to 2000 L mol-1, which are usual values for 
aromatic compounds.30 No Kc values for HP-α- and HP-γ-CD have been described in 
previous literature, neither for these compounds nor for others of a similar nature. In fact, 
the vast majority of the available literature almost exclusively focuses on studying the 
interactions of different molecules with β- and HP-β-CD, which have been cited as the 
most suitable for the encapsulation of compounds of an aromatic nature.18,20,22,23  
The stability of a CD complex depends on an adequate inclusion of the host 
molecule inside the hydrophobic cavity of the CD molecule. Based on the classification 
proposed by Carrier et al.,31 the stability of carvacrol and thymol complexes with HP-α- 
and HP-γ-CDs could be classified as very weak (0-500 L mol-1), while that of 
complexation with HP-β-CD would be between weak (500-1000 L mol-1) and moderate 
(1000-5000 L mol-1). The Kc values obtained in this study suggest that the size of HP-α-
CD could be too small for carvacrol and thymol to be able to complete their encapsulation 
within the hydrophobic cavity. On the other hand, the cavity size of HP-γ-CD could be 
too large, thereby causing carvacrol and thymol molecules to fail to establish a sufficient 
amount of stable interactions with hydrophobic cavity atoms. In previous studies carried 
out with these and similar molecules, it has been observed that the Kc complexation 
constants with native CDs have been generally higher for β-CD than for α- and γ-
CD.12,18,22 Obtaining complexes with a different stability by using different CDs could 




Kc indicates complexation strength or complex stability, and it is normally used 
to compare the affinity of any guest molecule with different CD types. However, in order 
to analyze the solubilizing effect of CDs, complexation efficiency (CE) is more suitable 
because it is independent of S0. CE represents the ratio between complex and free CD 
concentration, and, for 1:1 complexes, it can be calculated from the slope of the phase 
solubility diagram with equation (2).32 In addition, CE can be used to calculate the molar 
ratio (D:CD), which indicates the ratio between the number of CD-forming complexes 
and the total number of CDs in solution (equation 3).  
The obtained values of CE and molar ratio are shown in Table 1. The highest CE 
value was obtained for the carvacrol-HP-β-CD complex (1769.2 %) followed by the 
thymol-HP-β-CD complex (537.8 %). These values are similar to those obtained by other 
authors for the same compounds and CDs.18 Significantly lower values (p < 0.05) were 
observed for carvacrol and thymol complexes with HP-γ-CD (285.2 % and 146.2 %, 
respectively). The lowest complexation efficacy values were displayed by carvacrol and 
thymol complexes with HP-α-CD (92.4 % and 68.6 %, respectively). In general, the CE 
values obtained in this study were higher than those reported by other authors for different 
types of compounds and CDs.32 CE values close to or even greater than 100 % mean that 
there was a higher proportion of CD-forming soluble complexes than of free CDs, which 
indicates that CDs were being used effectively to solubilize the guest molecule by forming 
soluble complexes. Almost all of the dissolved HP-β- and HP-γ-CD molecules were 
complexed with a carvacrol molecule, as shown by the 1:1.1 and 1:1.4 molar ratio, 
respectively (Table 1). The behaviour of thymol complexes was similar, with a molar 
ratio of 1:1.2 and 1:1.7 for HP-β- and HP-γ-CD, respectively. HP-α-CD complexes 
displayed a lower molar ratio than HP-β- and HP-γ-CD, indicating that one of each two 
 
 
molecules of HP-α-CD in solution were forming soluble complexes (1:2.1 and 1:2.5 for 
carvacrol and thymol, respectively). 
The solubilization potential (St/S0) was comparable in carvacrol and thymol, 
although slightly higher values were obtained for thymol than for carvacrol, mainly due 
to the lower S0 value of thymol (Table 1), as suggested by previous studies.18 At a CD 
concentration of 50 mmol L-1, the solubility of carvacrol and thymol increased more than 
7-fold with HP-β-CD and almost 6-fold with HP-γ-CD, which indicates the high 
solubilization potential not only of HP-β-CD but also of HP-γ-CD. HP-α-CD has shown 
a significantly (p < 0.05) lower solubilization potential, increasing the aqueous solubility 
4.07 and 4.30-fold for carvacrol and thymol, respectively. 
 
Characterization of solid complexes 
Table 2 shows the characterization parameters of the solid complexes of carvacrol 
and thymol with HP-α-, HP-β-, and HP-γ-CD dehydrated by freeze- or spray-drying. 
Dehydration yield (DY, grams of solid complex recovered with respect to the initial 
grams of soluble solids, equation 4) was higher for freeze-drying than for spray-drying. 
On average, freeze-drying obtained a recovery yield of 93 % in contrast with 80 % for 
spray-drying. Despite the lower values for spray-drying relative to freeze-drying, the 
spray-drying DY of 80 % was over 50 %, which is the minimum recommended recovery 
rate for adequate dehydration process efficiency.33 This fact indicates that conditions of 
temperature, inlet air flow, and atomization level were adequate for obtaining solid 
complexes by spray-drying. On the other hand, a slightly increasing trend was observed 
in the dehydration yield from HP-α- < HP-β- < HP-γ-CD. This increasing trend could be 
due to the fact that the preparation of solid complexes was carried out with the same initial 
CD concentration of 50 mmol L-1, which means that the initial amount of soluble solids 
 
 
was increasing from HP-α- < HP-β- < HP-γ-CD, thereby resulting in a more efficient 
recovery of dehydrated complexes.34 
Encapsulation efficiency (EE, equation 5) represents the amount of active matter 
that has been recovered after the dehydration process, indicating whether significant 
compound losses occur during the dehydration process. For all the solid complexes 
obtained, EE was significantly higher (p < 0.05) for freeze-drying than for spray-drying. 
On average, the encapsulation efficiency for freeze-drying was 93.5 %. These values 
were similar to those obtained by Kfoury et al.30 for thymol encapsulated in HP-β-CD, 
and slightly higher than those provided by Kamimura et al.16 for carvacrol likewise 
encapsulated in HP-β-CD, as well as by Hill et al.3 for aromatic compounds that were 
similar although encapsulated in other CDs. The low temperature conditions of the freeze-
drying process were key in limiting aromatic compound losses during the process. On the 
other hand, the EE of spray-drying ranged from 64.9 to 88.8 % for carvacrol, and from 
70.2 to 79.8 % for thymol.  
Regarding the effect of CD type on EE, no statistically significant differences (p 
> 0.05) were observed among freeze-dryied dehydrated complexes, except between 
thymol complexes with HP-α-CD and with HP-β-CD. When complexes were dehydrated 
by spray-drying, EE was higher for HP-α-CD and lower for HP-γ-CD, with HP-β-CD in 
an intermediate position. A high concentration of soluble solids, as occurred with HP-γ-
CD, could increase the solution’s viscosity prior to being sprayed, which can negatively 
affect the retention of encapsulated compounds.35 Kfoury et al. also observed a reduction 
in EE for native CDs in the α-CD > β-CD > γ-CD trend.12 
  In relation to the amount of compound that can be encapsulated per gram of 
complex (drug load, DL, equation 6), the freeze-drying process showed higher values 
than spray-drying, with statistically significant differences (p < 0.05) for all solid 
 
 
complexes studied. Regarding the effect of CD type, HP-β-CD had the highest DL value 
for both carvacrol and thymol, and for both the freeze-drying and the spray-drying 
method. From a toxicological and economic point of view, increasing DL can be 
advantageous for the bulk formulation and bioavailability of active material.36 However, 
it should be noted that when complexes were prepared with HP-α-CD and spray-dried, 
the lower compound:CD molar ratio and the adequate EE enabled HP-α-CD to have a 
DL close to that of HP-β-CD, with no statistical differences (p > 0.05) between these CDs 
for carvacrol solid complexes. 
One of the physical characteristics of solid complexes that was most affected by 
the dehydration method was wettability (Table 2). This parameter is affected by different 
factors such as particle size, water content, and crystalline structure. All solid complexes 
dehydrated by freeze-drying had a wettability time under 1 s, without any observable 
difference between CDs or compounds. However, spray-dried complexes had a much 
higher wettability time. The difference in wettability behavior between dehydration 
methods is probably related to the solubilization capacity associated with the different 
crystal and particle structures that result from using a specific procedure. Figure 2 shows 
the FESEM images of the particles obtained by freeze-drying (Figure 2 A, B) and spray-
drying (Figure 2 C, D) for the solid complexes of carvacrol with HP-β-CD. These images 
were representative of the other solid complexes obtained, regardless of CD type or 
encapsulated compound. One can observe that the particles of the freeze-dried solid 
complexes were composed of crystals with angular, sharp shapes and straight edges. 
Similar shapes were obtained by Tao et al.25 for thymol and β-CD complexes. Conversely, 
solid complexes dehydrated by the spray-drying method showed the typical wrinkled 
globular structure of particles obtained through this procedure.37 The capacity of water to 
interact with the crystalline structure of freeze-dried complexes could be closely related 
 
 
to the short wettability times, which cause an instantaneous dissolution of the lyophilized 
solid complexes in water. On the other hand, the use of high temperatures in the spray-
drying process allows for a semi-permeable membrane to be formed on the surface of the 
particles, which could slow down the powder’s wettability.4  
 
Antimicrobial activity of solid complexes   
Antimicrobial activity of the solid complexes was initially monitored by using the 
inhibition halo technique, for E. coli O157:H7 Sakai as representative of a Gram-negative 
bacterium, and for S. aureus USA300 as representative of Gram-positive types. This 
technique has been previously used to evaluate the antimicrobial activity of EOs 
encapsulated in CDs.9,10 In view of their high EE and DL, freeze-dried solid complexes 
were selected to carry out a preliminary evaluation of the antimicrobial activity of 
carvacrol and thymol complexed in modified CDs. Table 3 shows the results of the 
inhibition halos of freeze-dried solid complexes of carvacrol and thymol encapsulated 
with HP-α-, HP-β-, and HP-γ-CD against E. coli O157:H7 Sakai and against S. aureus 
USA300. The use of this basic technique revealed the relevance of CD type for the 
antimicrobial activity of carvacrol and thymol. As shown in Table 3, inhibition halos for 
both E. coli O157:H7 Sakai and S. aureus USA300 were significantly higher (p < 0.05) 
for both HP-α-CD and HP-γ-CD than those for HP-β-CD. In order to analyze the 
interactions between the microorganisms and the complexes in further detail, we carried 
out MIC and MBC determinations. 
Table 4 shows the MIC and MBC values for E. coli O157:H7 Sakai and for S. 
aureus USA300 of carvacrol and thymol free and encapsulated in HP-α-, HP-β-, and HP-
γ-CD. MIC values of free compounds ranged from 150 to 200 mg L-1, and MBC values 
from 200 to 250 mg L-1. These values are similar to those previously reported in the 
 
 
literature,38,39,40,41 but lower than other previous research works.16,17,20 When carvacrol 
and thymol were encapsulated, antimicrobial activity was reduced to a greater or lesser 
extent as a function of the type of CD used for encapsulation. For freeze-dried complexes, 
carvacrol and thymol encapsulation in HP-α-CD and HP-γ-CD maintained the 
antimicrobial activity against E. coli O157:H7 Sakai and S. aureus USA300 very close to 
that exhibited by the free compounds, increasing MIC and MBC values only by 50 mg L-
1 for most cases studied. However, when both compounds were encapsulated in HP-β-
CD, antimicrobial activity was clearly reduced. The freeze-dried complexes presented 
MIC values four and two times higher than free carvacrol and thymol, respectively. 
Regarding bactericidal activity, the MBC values of HP-β-CD freeze-dried complexes 
were four and three times higher than those of free compounds, exceeding, in some cases, 
the maximum tested concentration of 1,000 mg L-1. 
Many authors have previously studied the effect of CD encapsulation on the 
biological properties, mainly the antimicrobial and antioxidant activity, of EOs and/or 
their components. However, conclusive results cannot be reached. In contrast with our 
results, Kamimura et al.16 and Santos et al.17 observed a significant increase in the 
antimicrobial activity of carvacrol encapsulated in HP-β-CD and β-CD against E. coli 
K12 and S. Typhimurium LT2 with respect to the free compound, although encapsulation 
conversely reduced antioxidant capacity. Rodríguez et al.20 also concluded that 
encapsulation in HP-β-CD improved the antimicrobial capacity of carvacrol and thymol 
against E. coli CECT 943 and S. aureus CECT 239. Similar conclusions have likewise 
been reached by other authors.3,14 On the other hand, Anaya-Castro et al.9 observed that 
encapsulation of mexican oregano EO in β-CD did not significantly affect its 
antimicrobial activity, and Dima et al.10 reported a decrease in the antimicrobial and 
antioxidant capacity of coriander EO encapsulated in β-CD with respect to free EO. 
 
 
Regarding other biological processes such as antifungal activity, Del Toro-Sánchez et 
al.11 observed that the encapsulation of thyme EO in β-CD reduced its antifungal capacity, 
and Kfoury et al.42 determined that antifungal activity of phenylpropanoids was reduced 
when encapsulated in HP-β-CDs. This disparity in the results of previous studies has 
already been indicated by Kfoury et al., who concluded that the effect of encapsulation in 
CDs on the biological activity of aromatic compounds can present effects that do not 
always go in the same direction.21 One of the reasons that could explain this disparity in 
results may be related to the use of different methodologies for the characterization of 
antimicrobial activity of free compounds, which can lead to a wide range of MIC and 
MBC values reported. Based on previous work, the methodology used in this study only 
applied vigorous shaking as a method to ensure sufficient dispersion of the terpene in the 
culture medium.43 Using this methodology, values of MIC and MBC obtained in this 
study were in consensus with those reported in previous studies.38,39,40,41 However, when 
additional actions were carried out to disperse the terpenes in the culture medium, such 
as the use of surfactants, the values of MIC and MBC of the terpenes in free state were 
higher.16,17,20 As a result, these authors observed a significant increase in the antimicrobial 
activity of encapsulated compunds, while those who reported lower MIC and MBC values 
for free compounds, as concluded in this study, affirmed that efficiency was maintained 
or decreased.9,10   
Taken into account the method used for antimicrobial activity determination in 
this study, this research demonstrated that encapsulation in CDs reduces, to a greater or 
lesser extent, the antimicrobial capacity of carvacrol and thymol, proving that the stability 
of the complexes, defined as the Kc values and dependent on the type of CD, can modulate 
these compounds’ antimicrobial activity. The highest Kc value, which was determined for 
the carvacrol-HP-β-CD complex (2268.1 L mol-1, Table 1), indicates a greater stability 
 
 
of carvacrol-HP-β-CD but a lower amount of release of the antimicrobial compound. As 
a consequence, the antimicrobial activity of such compounds would decrease, as 
demonstrated by the highest MIC and MBC value obtained by the freeze-dried HP-β-CD 
complexes. Furthermore, it was determined that encapsulation of carvacrol and thymol in 
HP-α-CD and HP-γ-CD, not previously studied in the literature, provided a lower Kc 
value than HP-β-CD (Table 1), thereby allowing a more efficient release of the 
compounds while scarcely affecting their antibacterial activity.  
 Regarding the effect of the type of dehydration method used to obtain solid 
complexes, it was observed that spray-drying reduced the antimicrobial activity of 
carvacrol and thymol in relation to the antimicrobial activity of freeze-dried complexes. 
The MIC and MBC values (Table 4) of HP-α-CD complexes were, on average, 160 % 
and 147 % higher for spray-dried than for freeze-dried complexes, respectively. For 
carvacrol-HP-β-CD complexes, the MIC values increased from 700 mg L-1 (freeze-dried) 
to over 1,000 mg L-1 (spray-dried) for both bacteria, whereas for thymol-HP-β-CD 
complexes the MIC values were, on average, 95 % higher for spray-dried than for freeze-
dried complexes. The reduction in antimicrobial activity of spray-dried complexes may 
be related to the high temperatures to which such complexes are subjected during the 
dehydration process, thereby negatively affecting the antimicrobial capacity of the 
antibacterial compounds,44 as well as to the lower ease of water dissolution of spray-dried 
complexes as shown by their degree of wettability (Table 2), which could hamper the 
interaction of antimicrobial compounds with bacteria. However, HP-γ-CDs have been 
shown to better protect the antimicrobial capacity of carvacrol and thymol after spray-
drying than HP-α-CD or HP-β-CD. In the case of HP-γ-CD spray-dried complexes, the 
loss of antimicrobial activity resulted in an increase of MIC values lying between 0 and 
50 mg/L for carvacrol against E. coli O157:H7 Sakai and against S. aureus USA300, 
 
 
respectively, and corresponding to 100 mg L-1 for thymol against both microorganisms. 
On the one hand, the Kc values of 365.7 and 239.7 L mol-1 for carvacrol and thymol with 
HP-γ-CD (Table 1) may be high enough to protect the compounds during the dehydration 
process, but, on the other hand, these Kc values were still sufficiently low to allow for fast 
release of the compound when it was rehydrated. In addition, the solubilization potential 
values (St/S0) of HP-γ-CD were significantly higher than those of HP-α-CD, allowing for 
better water dissolution of antimicrobial compounds and thus improving their 
antimicrobial capacity.  
 
CONCLUSION 
In conclusion, this research shows that modified HP-α-CD and HP-γ-CD 
represent a very suitable alternative for carvacrol and thymol encapsulation, since they 
obtain complexes with a lower Kc value and release the compounds more readily, thus 
leading to bacteriostatic and bactericidal activities significantly higher than the complexes 
with HP-β-CD that are normally used for the encapsulation of these compounds. In this 
regard, it was observed that the HP-β-CD encapsulation of carvacrol and thymol 
drastically reduces their antimicrobial activity. Therefore, in order to consider the use of 
HP-β-CD for the encapsulation of this type of compound, it would be necessary to study 
mechanisms that activate the release of the host molecule from the inner cavity of the CD: 
procedures such as combined treatments with changes in pH and/or temperature. On the 
other hand, freeze-drying is the preferable alternative to obtain solid complexes with the 
purpose of maintaining the antimicrobial activity of carvacrol and thymol after 
encapsulation, although the spray-dry method, mainly combined with HP-γ-CD, allows 
for the obtention of solid complexes that maintain an antimicrobial activity of an efficacy 





This study was financially supported by MINECO (Spanish Ministry of Economy and 
Competitiveness, Project No. PGC2018-093789-B-I00), by the European Social Fund, 
and by the Aragonese Office of Science, Technology and University Research. 
 
CONFLICT OF INTEREST 
The authors declare that this research was carried out in the absence of commercial or 
financial relationships that could be constructed as a possible conflict of interest. 
 
REFERENCES 
1. Rivera J, Crandall PG, O’Bryan CA, and Ricke SC, Essential oils as antimicrobials in 
food systems – A review. Food Control 54:111-119 (2015). 
https://doi.org/10.1016/j.foodcont.2014.12.040 
2. Ju J, Chen X, Xie Y, Yu H, Gou Y, Cheng Y, Qian H and Yao W, Application of 
essential oils as a sustained release preparation in food packaging. Trends Food Sci 
Technol 92:22-32 (2019).  https://doi.org/10.1016/j.tifs.2019.08.005 
3. Hill LE, Gomes C, and Taylor TM, Characterization of beta-cyclodextrin inclusion 
complexes containing oils (trans-cinnamaldehyde, eugenol, cinnamon bark, and clove 
bud extracts) for antimicrobial delivery applications. LWT–Food Sci Technol 51:86-
93 (2013). https://doi.org/10.1016/j.lwt.2012.11.011 
4. Alvarenga D, de Barros RV and Vilela S, Microencapsulation of Essential oils using 
spray drying technology, in Microencapsulation and Microspheres for Food 




5. El Asbahani A, Miladi K, Badri W, Sala M, Aït Addi EH, Casabianca H, El Mousadik 
A, Hartmann D, Jilale A, Renaud FNR and Elaissari A, Essential oils: From extraction 
to encapsulation. Int J Pharm 483:220-243 (2015). 
https://doi.org/10.1016/j.ijpharm.2014.12.069 
6. Hasheminejad N, Khodaiyan, F, and Safari M, Improving the antifungal activity of 
clove essential oil encapsulated by chitosan nanoparticles. Food Chem 275:113-122 
(2019). https://doi.org/10.1016/j.foodchem.2018.09.085 
7. Merino N, Berdejo D, Bento R, Salman H, Lanz M, Maggi F, Sánchez-Gómez S, 
García-Gonzalo D and Pagán R, Antimicrobial efficacy of Thymbra capitata (L.) Cav. 
essential oil loaded in self-assembled zein nanoparticles in combination with heat. Ind 
Crop Prod 113:98-104 (2019). https://doi.org/10.1016/j.indcrop.2019.03.003 
8. Astray G, Gonzalez-Barreiro C, Mejuto JC, Rial-Otero R and Simal-Gándara J, A 
review on the use of cyclodextrins in foods. Food Hydrocolloids 23:1631-1640 (2009). 
https://doi.org/10.1016/j.foodhyd.2009.01.001 
9. Anaya-Castro MA, Ayala-Zavala JF, Muñoz-Castellanos L, Hernández-Ochoa L,  
Peydecastaing J and Durrieu V, β-Cylodextrin inclusion complexes containing clove 
(Eugenia caryophyllata) and mexicano regano (Lippia berlandieri) essential ois: 
Preparation, physochemical and antimicrobial characterization. Food Packaging Shelf 
14:96-101 (2017). https://doi.org/10.1016/j.fpsl.2017.09.002 
10. Dima C, Cotarlet M, Tiberius B, Hahrim G, Alexe P and Dima S, Encapsulation of 
coriander essential oil in beta-cyclodextrin: antioxidant and antimicrobial properties 
evaluation. Rom Biotech Lett 19:9128-9140 (2014). http://e-
repository.org/rbl/vol.19/iss.2/4.pdf 
11. Del Toro-Sánchez CL, Ayala-Zavala JF, Machi L, Santacruz H, Villegas-Ochoa MA, 
Álvarez-Parrilla E and González-Aguilar GA, Controlled release of antifungical 
 
 
volatiles of thyme essential oil from β-cyclodextrin capsules. J Incl Phenom 
Macrocycl Chem 67:431-441 (2010). 
https://link.springer.com/article/10.1007/s10847-009-9726-3 
12. Kfourly M, Auezova L, Ruellan S, Greige-Gerges H and Fourmentin S, Complexation 
of estragole as pure compound and as main component of basil and tarragon essential 
oils with cyclodextrins. Carbohydr Polym 118:156-164 (2015). 
https://doi.org/10.1016/j.carbpol.2014.10.073 
13. Martins AP, Craveiro AA, Machado MIL, Raffin FN, Moura TF, Novák CS and Éhen 
Z, Preparation and characterization of Mentha x Villosa Hudons oil-β-cyclodextrin 
complex. J Therm Anal 88:363-371 (2007). 
https://link.springer.com/article/10.1007/s10973-005-7407-z 
14. Rakmai J, Cheirsilp B, Mejuto JC, Simal-Gándara J and Torrado-Agrasar A, 
Antioxidant and antimicrobial properties of encapsulated guava leaf oil in 
hydroxypropyl-beta-cyclodextrin. Ind Crop Prod 111:219-225 (2018). 
15. Suprani C, Gonçalves S, Diirr L, Oliveira JC, Fontes P, Moreira D, Yoshida MI, 
Checon JC, Fernandes D and Campos P, β-Cyclodextrin inclusion complexes with 
essential oils: Obtention, characterization, antimicrobial activity and potential 
application for food preservative sachets. Food Res Int 119:499-509 (2019). 
https://doi.org/10.1016/j.foodres.2019.01.016 
16. Kamimura JA, Santos EH, Hill LE and Gomes CL, Antimicrobial and antioxidant 
activities of carvacrol microencapsulated in hydroxypropyl-beta-cyclodextrin. LWT–
Food Sci Technol 57:701-709 (2014). https://doi.org/10.1016/j.lwt.2014.02.014 
17. Santos EH, Kamimura JA, Hill LE and Gomes CL, Characterization of carvacrol beta-
cyclodextrin inclusion complexes as delivery systems for antibacterial and antioxidant 
 
 
applications. LWT-Food Sci Technol 60:583-592 (2015). 
https://doi.org/10.1016/j.lwt.2014.08.046 
18. Kfoury M, Landy D, Ruellan S, Auezova L, Greige-Gerges H and Fourmentin S, 
Determination of formation constants and structural characterization of cyclodextrin 
inclusion complexes with two phenolic isomers: carvacrol and thymol. J Org Chem 
12:29-42 (2016). https://www.beilstein-journals.org/bjoc/articles/12/5 
19. Rodríguez-López MI, Mercader-Ros MT, López-Miranda S, Pellicer JA, Pérez-
Garrido A, Pérez-Sánchez H, Núñez-Delicado E and Gabaldón JA, Thorough 
characterization and stability of HP-𝜷𝜷-cyclodextrin thymol inclusion complexes 
prepared by microwave technology: A required approach to a successful application 
in food. J Sci Food Agr 99: 1322-1333 (2018). https://doi.org/10.1002/jsfa.9307 
20. Rodríguez-López, MA, Mercader-Ros MT, Pellicer JA, Gómez-López V, Martínez-
Romero D, Núñez-Delicado E, and Gabaldón JA, Evaluation of monoterpene-
cyclodextrin complexes as bacterial growth effective hurdles. Food Control 
108:106814 (2020). https://doi.org/10.1016/j.foodcont.2019.106814 
21. Kfourly M, Auezova L, Greige-Gerges H and Fourmentin S, Cyclodextrin for 
Essential Oils Applications. I Cyclodextrin Application,  in Cyclodextrin Applications 
in Medicine, Food, Environment and Liquid Crystals, ed. by Fourmentin S, Crini S 
and Lichtfouse E. Springer, Berlin, pp. 81-123 (2018). https://doi.org/10.1007/978-3-
319-76162-6_4 
22. Kfoury M, Landy D and Fourmentin, S, Characterization of cyclodextrin/volatile 
inclusion complexes: a review. Molecules 23:1204 (2018). 
https://doi.org/10.3390/molecules23051204 
23. Rakmai J, Cheirsilp B, Cid A, Torrado-Agrasar A, Mejuto JC and Simal-Gandara J, 
Encapsulation of Essential oils by cyclodextrins: characterization and evaluation, in 
 
 
Cyclodextrin: a versatile ingredient, ed. by Aroa P and Dhingra N. IntechOpen, 
London, pp. 236-290 (2018). http://dx.doi.org/10.5772/intechopen.73589 
24. Lima P, Lucchese A, Araújo-Filho H, Menezes P, Araújo A, Quintans-Júnior L and  
Quintans J, Inclusion of terpenes in cyclodextrins: preparation, characterization and 
pharmacological approaches. Carbohydr Polym 151:965-987 (2016). 
https://doi.org/10.1016/j.carbpol.2016.06.040 
25. Tao F, Hill LE, Peng Y and Gomes CL, Synthesis and characterization of β-
cyclodextrin inclusion complexes of thymol and thyme oil for antimicrobial delivery 
applications. LWT-Food Sci Technol 59:247-255 (2014). 
https://doi.org/10.1016/j.lwt.2014.05.037 
26. Higuchi T and Connors KA, Phase solubility techniques. Advances in Analytical 
Chem Instrum 4:56-63 (1965). 
27. Kim SH, Lee SR, Kim KS, Ko A, Kim E, Kim YH and Chang KT, Shiga toxin A 
subunit mutant of Escherichia coli O157:H7 releases outer membrane vesicles 
containing the B-pentameric complex. FEMS Immunol Med Microbiol 58:412–420 
(2010). https://doi.org/10.1111/j.1574-695X.2010.00654.x 
28. Kreiswirth B, Kornblum J, Arbeit RD, Eisner W, Maslow JN, McGeer A, Low DE 
and Novick RP, Evidence for a clonal origin of methicillin resistance in 
Staphylococcus aureus. Science 259:227-230 (1993). 
https://doi.org/10.1126/science.8093647. 
29. Meena MR and Sethi V, Antimicrobial activity of essential oils from spices. J Food 
Sci Technol - Mysore 31:68-70 (1994). 
30. Kfoury M, Auezova L, Fourmentin S and Greige-Gerges H, Investigation of 
monoterpenes complexation with hydroxipropyl-β-cyclodextrin. J Incl Phenom 
 
 
Macrocycl Chem 80:51-60 (2014). https://link.springer.com/article/10.1007/s10847-
014-0385-7 
31. Carrier RL, Miller LA and Ahmed I, The utility of cyclodextrins for enhancing oral 
bioavailability. J Control Release 123:78-99 (2007). 
https://doi.org/10.1016/j.jconrel.2007.07.018 
32. Loftsson T, Hreinsdóttir D and Másson M, The complexation efficiency. J Incl 
Phenom Macrocycl Chem 57:545-552 (2007). 
https://link.springer.com/article/10.1007/s10847-006-9247-2 
33. Fang Z and Bhandari B, Effect of spray drying and storage on the stability of bay 
berry polyphenols. Food Chem 129:1139-1147 (2011). 
https://doi.org/10.1016/j.foodchem.2011.05.093 
34. Tontul I and Topuz A, Spray-drying of fruit and vegetable juices: Effect of drying 
conditions on the product yield and physical properties. Trends Food Sci Technol 
63:91-102 (2017). https://doi.org/10.1016/j.tifs.2017.03.009 
35. De Barros RV, Borges SV and Botrel DA, Gum Arabic / starch / maltodextrin / inulin 
as wall materials on the microencapsulation of rosemary essential oil. Carbohydr 
Polym 101:524-532 (2014). https://doi.org/10.1016/j.carbpol.2013.09.083 
36. Loftsson T, Hreinsdottir D and Masson M, Evaluation of cyclodextrin solubilization 
of drugs. Int J Pharm 302:18-28 (2005). 
https://doi.org/10.1016/j.ijpharm.2005.05.042 
37. Wang S, Shi Y and Han L, Development and evaluation of microencapsulated peony 
seed oil prepared by spray drying: oxidative stability and its release behavior during 




38. Ait-Ouazzou A, Cherrat L, Espina L, Lorán S, Rota C and Pagán R, The antimicrobial 
activity of hydrophobic essential oil constituents acting alone or in combined processes 
of food preservation. Innov Food Sci Emerg Technol 12:320-329 (2011). 
https://doi.org/10.1016/j.ifset.2011.04.004 
39. Espina L, Pagán R, López D, García-Gonzalo D, Individual constituents from 
essential oils inhibit biofilm mass production by multi-drug resistant Staphylococcus 
aureus. Molecules 20:11357-11372 
(2015).   https://doi.org/10.3390/molecules200611357 
40. Chueca B, Berdejo D, Gomes-Neto NJ, Pagán R and García-Gonzalo D, Emergence 
of hyper-resistant Escherichia coli MG1655 derivative strains after applying sub-
inhibitory doses of individual constituents of essential oils. Front. Microbiol. March 
2016 (7):273 (2016).  https://doi.org/10.3389/fmicb.2016.00273 
41. García-Salinas S, Elizondo-Castillo H, Arruebo M, Mendoza G and Irusta S, 
Evaluation of the antimicrobial activity and cytotoxicity of different components of 
natural origin present in essential oils. Molecules 23:1-18 (2018). 
https://doi.org/10.3390/molecules23061399 
42. Kfoury M, Sahraoui A, Bourbon N, Laruelle F, Fontaine J, Auezova L, Greige-Gerges 
H and Fourmentin S, Solubility, photostability and antifungal activity of 
phenylpropanoids encapsulated in cyclodextrins. Food Chem 196:518-525 (2016). 
https://doi.org/10.1016/j.foodchem.2015.09.078 
43. Friedman M, Henika PR, Mandrell RE, Bactericidal activities of plant essential oils 
and some of their isolated constituents against Campylobacter jejuni, Escherichia 




 44. Dos Santos R, Da Silva RA, Corso MP, and Canan, C. Essential oils 






























Table 1. Aqueous solubility (S0), complexation constant (Kc), complexation efficiency 
(CE), Molar Ratio (D:C), and solubility ratio (St/S0) at 50 mmol L-1 of CDs for carvacrol 
and thymol for HP-α-CD, HP-β-CD, and HP-γ-CD.  










118.4±4.8a 92.4±3.8a 1:2.1±0.04c 4.07±0.14ª 
HP-β-CD 2268.2±184.2c 1769.2±143.7c 1:1.1±0.00a 7.05±0.18c 




112.5±3.1a 68.6±1.9a 1:2.5±0.04c 4.30±0.12ª 
HP-β-CD 881.6±6.6c 537.8±4.0c 1:1.2±0.00a 7.85±0.01c 
HP-γ-CD 239.7±2.0b 146.2±1.2b 1:1.7±0.01b 5.85±0.00b 
Values represent means of triplicate determination (±Standard deviation). 


















Table 2. Dehydration yield (DY, %), encapsulation efficiency (EE, %), drug load (DL, 
mg g-1), and wettability (s) of solid complexes by freeze-drying (FD) and spray-drying 
(SD) for carvacrol and thymol encapsulated with HP-α-CD, HP-β-CD, and HP-γ-CD.  
  DY (%) EE (%) DL (mg g-1) Wettability (s) 
Compound CD FD SD FD SD S.S FD SD S.S FD SD S.S 
Carvacrol 
HP-α-CD 92.3 77.6 96.5±0.2ª 88.8±3.2b ** 59.0±0.1b 53.6±1.9b ** <1ª 22.3±1.5ª ** 
HP-β-CD 89.8 79.5 98.1±1.7ª 81.6±7.7b * 72.5±1.2c 59.4±5.6b * <1ª 53.3±5.5ª ** 
HP-γ-CD 94.1 81.9 95.7±1.7ª 64.9±3.5ª ** 40.9±0.7ª 28.1±1.5ª ** <1ª 145.3±27b ** 
Thymol 
HP-α-CD 90.0 77.5 88.3±1.6ª 79.8±2.0c ** 54.8±1.0b 49.2±1.2b ** <1ª 24.3±4.5ª ** 
HP-β-CD 92.3 79.6 99.2±0.1b 75.2±0.5b ** 73.07±0.1c 54.5±0.4
c ** <1ª 67.3±4.0b ** 
HP-γ-CD 97.7 85.0 94.3±5.7ab 70.2±1.0a ** 39.5±2.4ª 29.9±0.4ª ** <1ª 156.7±28.4c ** 
Values represent means of triplicate determination (±Standard deviation) 
In each column, the statistical difference between means of HP-α, HP-β, and HP-γ-CD for each compound is shown (p < 0.05) (a-c). 















Table 3. Inhibition halos (mm) for carvacrol and thymol against Escherichia coli 
O157:H7 Sakai and Staphylococcus aureus USA300 encapsulated in HP-α-, HP-β, and 
HP-γ-CD and dehydrated by freeze-drying; disk diameter 6.0 mm.  
  Inhibition halo (mm) 
Compound Encapsulation Escherichia coli Staphylococcus aureus 
Carvacrol 
HP-α-CD 12.7±0.4b 12.0±0.6c 
HP-β-CD 6.4±0.4a 7.1±0.5a 
HP-γ-CD 11.8±0.4b 10.4±0.1b 
Thymol 
HP-α-CD 13.7±0.3c 13.8±0.8c 
HP-β-CD 8.9±0.5a 8.2±0.1a 
HP-γ-CD 11.3±0.1b 11.8±0.5b 
Values represent means of triplicate determination (±Standard deviation) 















Table 4. Minimum inhibitory concentration (MIC; mg/L) and minimum bactericidal 
concentration (MBC; mg L-1) of carvacrol and thymol, free or encapsulated in HP-α-CD, 
HP-β-CD, and HP-γ-CD using the freeze-dry (FD) and spray-dry (SD) methods, against 
Escherichia coli O157:H7 Sakai and Staphylococcus aureus USA300.  
  MIC (mg L-1) MBC (mg L-1) 
  Escherichia coli Staphylococcus aureus Escherichia coli 
Staphylococcus 
aureus 
Compound Encapsulation FD SD FD SD FD SD FD SD 
Carvacrol 
Free 150 200 200 250 
HP-α-CD 200 600 250 600 250 900 450 900 
HP-β-CD 700 >1000 700 >1000 >1000 >1000 >1000 >1000 
HP-γ-CD 250 250 250 300 250 500 450 600 
Thymol 
Free 150 150 250 250 
HP-α-CD 200 500 200 500 250 500 350 800 
HP-β-CD 350 750 400 700 650 800 900 >1000 















Figure 1. Phase solubility diagrams of carvacrol (A) and thymol (B) with HP-α-CD (■), 
HP-β-CD (▲), and HP-γ-CD (●) in aqueous solution. 
 
Figure 2. Field Emission Scanning Electron Microscope (FESEM) images of freeze-dried 
(A and B) and spray-dried (C and D) complexes of carvacrol in HP-β-CDs 
 
A
cc
ep
te
d 
A
rti
cl
e
A
cc
ep
te
d 
A
rti
cl
e
